Skip to search formSkip to main contentSkip to account menu

O-2050

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes
2016
2016
Subcellular Localization of a 2-Arachidonoyl Glycerol Signaling Cassette in Retinal Ganglion Cell Axonal Growth In Vitro.
Purpose To investigate whether the subcellular distribution of endocannabinoid (eCB) system (ECS) components in growing RGC axons… 
2014
2014
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus
The cannabinoid CB1 receptors on the noradrenergic neurons in guinea pig hippocampal slices show an endogenous endocannabinoid… 
2013
2013
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans.
2012
2012
Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice.
2011
2011
Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.
2010
2010
Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea‐pig isolated ileum myenteric plexus‐longitudinal muscle…
Background and purpose:  Cannabinoid receptor agonists reduce intestinal propulsion in rodents through the CB1 receptor. In… 
2009
2009
Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress.
The present study was designed to determine the effect of delta(9)-tetrahydrocannabinol (THC) on susceptibility to stress. We… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)